Key result
Observation, growth hormone treatment, and low-dose oral oxandrolone in boys serve as the primary management options for idiopathic short stature in childhood.
This review outlines the evaluation and management options for children with idiopathic short stature.
Informs management of childhood idiopathic short stature; leaves open need for comparative long-term outcome trials.
This article reviews evaluation of short stature in childhood and options for management of idiopathic cases (e.g., familial short stature or constitutional delay of growth and puberty), including observation and reassurance, growth hormone treatment, and low-dose oral oxandrolone in boys.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2013) studied this question. Observation, growth hormone treatment, and low-dose oral oxandrolone in boys serve as the primary management options for idiopathic short stature in childhood.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: